Agastiya Biotech is a clinical stage oncology drug development company which uses AI:Intuit-Serendipity, an AI platform invented by Dr. Pillai, founder of Agastiya Biotech. AB001, the first molecule created through our technology, completed Phase I trial in India and Phase II is scheduled for October 2024 in 30 centers across India. We have also completed preclinical work for a KRAS inhibitor and a molecule for diabetes. Our mission is to make our medicines in India for equitable access purpose.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 1902 Wright Place,
- Phone
- +1-951-234-3142
- me****@****ech.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- agastiyabiotech.com
- Keywords
- Quantum AI.
- HQ
- Carlsbad, California
Agastiya Biotech Questions
Agastiya Biotech's helpline number is +1-951-234-3142
Agastiya Biotech's website is agastiyabiotech.com
Agastiya Biotech's LinkedIn profile is https://www.linkedin.com/company/agastiya-biotech
Agastiya Biotech has
6 employees.
View email and phone details for 6
employees at Agastiya Biotech.
Agastiya Biotech's industry is
Biotechnology Research
Agastiya Biotech's top competitors are
Elpida Therapeutics,
Scigenom Labs,
Design Therapeutics,
Sanjeev Biomedical Research Centre,
Jammi Pharmaceuticals,
Quantum Ai,
Tripura Foundation,
Curespg50,
Stedman Pharmaceuticals Private Limited,
Vopec Pharmaceuticals (P) Ltd.
Agastiya Biotech's support email address is media@agastiyabiotech.com
Agastiya Biotech's categories are Biotechnology Research
Agastiya Biotech's founding year is 2019
